Previous Page  38 / 156 Next Page
Information
Show Menu
Previous Page 38 / 156 Next Page
Page Background

36

IQ) as the BMR for IQ, a 1% increase in systolic blood pressure (SBP)

(equivalent to a 1.2 mmHg change) as the BMR for cardiovascular

effects; anda10% increase inexpected incidenceof chronic kidney

disease as the BMR for nephrotoxicity (EFSA 2010, Table 1).

Table 1:

Critical effects of lead, associated blood lead levels and corresponding dietary lead intake values

identified by the EFSA Panel on

Contaminants in the Food Chain (CONTAM – EFSA 2010)

Benchmark

Response (BMR)

BMDL (95th percentile

lower confidence limit

of the benchmark dose

– BMD of extra risk)

derived from blood

lead levels (μg/L)

Corresponding dietary

lead intake value (μg/

kg bw per day)

Population level effects of BMR

A 1% (1 point)

reduction in IQ in

young children

BMDL

01

= 12

0.50

The BMR for IQ could impact the socioeconomic status of

a population and its productivity. Studies in the USA have

related a 1 point reduction in IQ to a 4.5% increased risk of

failure to graduate from high school and a 2% decrease in

productivity in later life (Schwartz 1994, Grosse

et al.

2002).

A 1% increase

in systolic blood

pressure (SBP) in

adults (equivalent

to a 1.2 mm Hg

change)

BMDL

01

= 36

1.50

A 1% increase in SBP has been related to an increase in

the percentage of the population treated for hypertension

by 3.1%, and a 2.6% or 2.4% increase in expected annual

mortality from cerebral stroke or myocardial infarction

respectively (Selmer

et al.

2000).

A 10% increase in

expected incidence

of chronic kidney

disease in adults

BMDL

10

= 15

0.63

The JECFA PTWI was subsequently withdrawn in 2010/2011

(WHO 2007, JECFA 2010, WHO 2011).

EFSA findings on the hazards to

human health from dietary lead

in Europe

The EFSA CONTAM Panel used the Integrated Exposure Uptake

Biokinetic (IEUBK 2010) Model for lead in children (IEUBKwin

version 1.1) and an equation from Carlisle and Wade (1992)

for lead in adults to estimate the dietary intake of lead

(BMD) required to produce the elevations in B-Pb associated

with the BMR and also the BMDL, the lower one-sided 95%

confidence bound of the BMDs (Table 1). This modification

of the BMD allows for uncertainty in the dose-response

relationship. They also assessed data on lead concentrations

in foods in the European Union, including lead directly derived

from ammunition in game meat. EFSA used information

on lead concentrations in food and amounts of food eaten

by individuals in participating countries to calculate mean

(‘average base diet’) and 95th percentile (‘high base diet’)

lead dietary exposures separately for each country. These

exposure data were then used to produce corresponding B-Pb

concentrations, and these were compared with the BMDLs

to evaluate risk. In some assessments, groups of people

frequently consuming game meat (defined as one 200 g meal

per week of game) were considered separately. In calculating

the effects upon B-Pb of game meat consumption the EFSA

CONTAM Panel assumed that the bioavailability of dietary lead

directly derived from ammunition was the same as for other

sources of dietary lead. They obtained the ratio of dietary

exposure, assuming various diets, to the BMDLs. The risk of

Rhys E. Green & Deborah J. Pain